Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.
Identifieur interne : 003875 ( Main/Exploration ); précédent : 003874; suivant : 003876Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.
Auteurs : Charlie Gourley [États-Unis] ; John Farley ; Diane M. Provencher ; Sandro Pignata ; Linda Mileshkin ; Philipp Harter ; Johanna Maenpaa ; Jae-Weon Kim ; Eric Pujaide-Lauraine ; Rosalind M. Glasspool ; Isabelle Ray-Coquard ; David GershensonSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.
Descripteurs français
- KwdFr :
- Association thérapeutique, Consensus, Cystadénocarcinome séreux (), Cystadénocarcinome séreux (anatomopathologie), Femelle, Grading des tumeurs, Guides de bonnes pratiques cliniques comme sujet, Humains, Oncologie médicale, Sociétés médicales, Tumeurs de l'ovaire (), Tumeurs de l'ovaire (anatomopathologie), Tumeurs du péritoine (), Tumeurs du péritoine (anatomopathologie).
- MESH :
- anatomopathologie : Cystadénocarcinome séreux, Tumeurs de l'ovaire, Tumeurs du péritoine.
- Association thérapeutique, Consensus, Cystadénocarcinome séreux, Femelle, Grading des tumeurs, Guides de bonnes pratiques cliniques comme sujet, Humains, Oncologie médicale, Sociétés médicales, Tumeurs de l'ovaire, Tumeurs du péritoine.
English descriptors
- KwdEn :
- Combined Modality Therapy, Consensus, Cystadenocarcinoma, Serous (pathology), Cystadenocarcinoma, Serous (therapy), Female, Humans, Medical Oncology, Neoplasm Grading, Ovarian Neoplasms (pathology), Ovarian Neoplasms (therapy), Peritoneal Neoplasms (pathology), Peritoneal Neoplasms (therapy), Practice Guidelines as Topic, Societies, Medical.
- MESH :
Abstract
Low-grade serous ovarian cancer is a recently described histological subtype of ovarian cancer that is clinically and molecularly distinct from the 4 other main histological subtypes (high-grade serous, clear cell, endometrioid, and mucinous). In particular, it differs from high-grade serous ovarian cancer in that it presents at a much younger age, is more indolent, and is relatively chemoresistant. Very few clinical trials have been performed exclusively in this tumor type; and as such, specific data guiding optimal management are limited.
DOI: 10.1097/IGC.0000000000000257
PubMed: 25341587
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003289
- to stream PubMed, to step Curation: 003179
- to stream PubMed, to step Checkpoint: 003179
- to stream Ncbi, to step Merge: 001F36
- to stream Ncbi, to step Curation: 001F36
- to stream Ncbi, to step Checkpoint: 001F36
- to stream Main, to step Merge: 003910
- to stream Main, to step Curation: 003875
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.</title><author><name sortKey="Gourley, Charlie" sort="Gourley, Charlie" uniqKey="Gourley C" first="Charlie" last="Gourley">Charlie Gourley</name><affiliation wicri:level="2"><nlm:affiliation>*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Farley, John" sort="Farley, John" uniqKey="Farley J" first="John" last="Farley">John Farley</name></author><author><name sortKey="Provencher, Diane M" sort="Provencher, Diane M" uniqKey="Provencher D" first="Diane M" last="Provencher">Diane M. Provencher</name></author><author><name sortKey="Pignata, Sandro" sort="Pignata, Sandro" uniqKey="Pignata S" first="Sandro" last="Pignata">Sandro Pignata</name></author><author><name sortKey="Mileshkin, Linda" sort="Mileshkin, Linda" uniqKey="Mileshkin L" first="Linda" last="Mileshkin">Linda Mileshkin</name></author><author><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name></author><author><name sortKey="Maenpaa, Johanna" sort="Maenpaa, Johanna" uniqKey="Maenpaa J" first="Johanna" last="Maenpaa">Johanna Maenpaa</name></author><author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name></author><author><name sortKey="Pujaide Lauraine, Eric" sort="Pujaide Lauraine, Eric" uniqKey="Pujaide Lauraine E" first="Eric" last="Pujaide-Lauraine">Eric Pujaide-Lauraine</name></author><author><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name></author><author><name sortKey="Ray Coquard, Isabelle" sort="Ray Coquard, Isabelle" uniqKey="Ray Coquard I" first="Isabelle" last="Ray-Coquard">Isabelle Ray-Coquard</name></author><author><name sortKey="Gershenson, David" sort="Gershenson, David" uniqKey="Gershenson D" first="David" last="Gershenson">David Gershenson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25341587</idno><idno type="pmid">25341587</idno><idno type="doi">10.1097/IGC.0000000000000257</idno><idno type="wicri:Area/PubMed/Corpus">003289</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003289</idno><idno type="wicri:Area/PubMed/Curation">003179</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003179</idno><idno type="wicri:Area/PubMed/Checkpoint">003179</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003179</idno><idno type="wicri:Area/Ncbi/Merge">001F36</idno><idno type="wicri:Area/Ncbi/Curation">001F36</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F36</idno><idno type="wicri:Area/Main/Merge">003910</idno><idno type="wicri:Area/Main/Curation">003875</idno><idno type="wicri:Area/Main/Exploration">003875</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.</title><author><name sortKey="Gourley, Charlie" sort="Gourley, Charlie" uniqKey="Gourley C" first="Charlie" last="Gourley">Charlie Gourley</name><affiliation wicri:level="2"><nlm:affiliation>*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea></affiliation></author><author><name sortKey="Farley, John" sort="Farley, John" uniqKey="Farley J" first="John" last="Farley">John Farley</name></author><author><name sortKey="Provencher, Diane M" sort="Provencher, Diane M" uniqKey="Provencher D" first="Diane M" last="Provencher">Diane M. Provencher</name></author><author><name sortKey="Pignata, Sandro" sort="Pignata, Sandro" uniqKey="Pignata S" first="Sandro" last="Pignata">Sandro Pignata</name></author><author><name sortKey="Mileshkin, Linda" sort="Mileshkin, Linda" uniqKey="Mileshkin L" first="Linda" last="Mileshkin">Linda Mileshkin</name></author><author><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name></author><author><name sortKey="Maenpaa, Johanna" sort="Maenpaa, Johanna" uniqKey="Maenpaa J" first="Johanna" last="Maenpaa">Johanna Maenpaa</name></author><author><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name></author><author><name sortKey="Pujaide Lauraine, Eric" sort="Pujaide Lauraine, Eric" uniqKey="Pujaide Lauraine E" first="Eric" last="Pujaide-Lauraine">Eric Pujaide-Lauraine</name></author><author><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name></author><author><name sortKey="Ray Coquard, Isabelle" sort="Ray Coquard, Isabelle" uniqKey="Ray Coquard I" first="Isabelle" last="Ray-Coquard">Isabelle Ray-Coquard</name></author><author><name sortKey="Gershenson, David" sort="Gershenson, David" uniqKey="Gershenson D" first="David" last="Gershenson">David Gershenson</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Combined Modality Therapy</term><term>Consensus</term><term>Cystadenocarcinoma, Serous (pathology)</term><term>Cystadenocarcinoma, Serous (therapy)</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Neoplasm Grading</term><term>Ovarian Neoplasms (pathology)</term><term>Ovarian Neoplasms (therapy)</term><term>Peritoneal Neoplasms (pathology)</term><term>Peritoneal Neoplasms (therapy)</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Consensus</term><term>Cystadénocarcinome séreux ()</term><term>Cystadénocarcinome séreux (anatomopathologie)</term><term>Femelle</term><term>Grading des tumeurs</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire ()</term><term>Tumeurs de l'ovaire (anatomopathologie)</term><term>Tumeurs du péritoine ()</term><term>Tumeurs du péritoine (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Cystadénocarcinome séreux</term><term>Tumeurs de l'ovaire</term><term>Tumeurs du péritoine</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Cystadenocarcinoma, Serous</term><term>Ovarian Neoplasms</term><term>Peritoneal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Cystadenocarcinoma, Serous</term><term>Ovarian Neoplasms</term><term>Peritoneal Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term><term>Consensus</term><term>Female</term><term>Humans</term><term>Medical Oncology</term><term>Neoplasm Grading</term><term>Practice Guidelines as Topic</term><term>Societies, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Consensus</term><term>Cystadénocarcinome séreux</term><term>Femelle</term><term>Grading des tumeurs</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Oncologie médicale</term><term>Sociétés médicales</term><term>Tumeurs de l'ovaire</term><term>Tumeurs du péritoine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Low-grade serous ovarian cancer is a recently described histological subtype of ovarian cancer that is clinically and molecularly distinct from the 4 other main histological subtypes (high-grade serous, clear cell, endometrioid, and mucinous). In particular, it differs from high-grade serous ovarian cancer in that it presents at a much younger age, is more indolent, and is relatively chemoresistant. Very few clinical trials have been performed exclusively in this tumor type; and as such, specific data guiding optimal management are limited.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><noCountry><name sortKey="Farley, John" sort="Farley, John" uniqKey="Farley J" first="John" last="Farley">John Farley</name><name sortKey="Gershenson, David" sort="Gershenson, David" uniqKey="Gershenson D" first="David" last="Gershenson">David Gershenson</name><name sortKey="Glasspool, Rosalind M" sort="Glasspool, Rosalind M" uniqKey="Glasspool R" first="Rosalind M" last="Glasspool">Rosalind M. Glasspool</name><name sortKey="Harter, Philipp" sort="Harter, Philipp" uniqKey="Harter P" first="Philipp" last="Harter">Philipp Harter</name><name sortKey="Kim, Jae Weon" sort="Kim, Jae Weon" uniqKey="Kim J" first="Jae-Weon" last="Kim">Jae-Weon Kim</name><name sortKey="Maenpaa, Johanna" sort="Maenpaa, Johanna" uniqKey="Maenpaa J" first="Johanna" last="Maenpaa">Johanna Maenpaa</name><name sortKey="Mileshkin, Linda" sort="Mileshkin, Linda" uniqKey="Mileshkin L" first="Linda" last="Mileshkin">Linda Mileshkin</name><name sortKey="Pignata, Sandro" sort="Pignata, Sandro" uniqKey="Pignata S" first="Sandro" last="Pignata">Sandro Pignata</name><name sortKey="Provencher, Diane M" sort="Provencher, Diane M" uniqKey="Provencher D" first="Diane M" last="Provencher">Diane M. Provencher</name><name sortKey="Pujaide Lauraine, Eric" sort="Pujaide Lauraine, Eric" uniqKey="Pujaide Lauraine E" first="Eric" last="Pujaide-Lauraine">Eric Pujaide-Lauraine</name><name sortKey="Ray Coquard, Isabelle" sort="Ray Coquard, Isabelle" uniqKey="Ray Coquard I" first="Isabelle" last="Ray-Coquard">Isabelle Ray-Coquard</name></noCountry><country name="États-Unis"><region name="Texas"><name sortKey="Gourley, Charlie" sort="Gourley, Charlie" uniqKey="Gourley C" first="Charlie" last="Gourley">Charlie Gourley</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003875 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003875 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25341587
|texte= Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25341587" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |